Edition:
United Kingdom

Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

3.91USD
17 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.91
Open
$3.95
Day's High
$4.00
Day's Low
$3.86
Volume
23,882
Avg. Vol
21,303
52-wk High
$5.72
52-wk Low
$0.52

Latest Key Developments (Source: Significant Developments)

Cerecor announces leadership changes
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cerecor Inc :Cerecor announces leadership changes.Cerecor Inc - ‍Interim Chief Executive Officer John Kaiser and Chief Medical Officer Dr. Ronald Marcus stepping down​.Cerecor Inc - ‍Appoints Randal O. Jones and Robert C. Moscato, Jr. to board of directors​.Cerecor Inc - ‍ Names Robert Moscato as president and Chief Operating Officer​.Cerecor Inc - ‍Mariam Morris will continue as Cerecor's chief financial officer​.  Full Article

Cerecor reports Q3 earnings per share of $0.52
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cerecor Inc ::Cerecor Inc reports third quarter 2017 financial results.Q3 earnings per share $0.52.As of Sept 30, cash and cash equivalents were $24.0 million, escrowed cash receivable was $3.75 million and current liabilities were $4.8 million​.Expect existing cash and cash equivalents, initial proceeds from Janssen sale will fund operating expenditures through at least 2018​.  Full Article

Cerecor announces last patient enrolled in phase 2 clinical trial with CERC-501 for smoking cessation
Tuesday, 6 Sep 2016 

Cerecor Inc : Cerecor Announces Last Patient Enrolled In Phase 2 Clinical Trial With CERC-501 for smoking cessation . Top-Line phase 2 data expected in December 2016 .Planning to initiate a phase 2 study with CERC-501 as an adjunctive treatment of MDD in 2017.  Full Article

BRIEF-Cerecor Q4 Loss Per Share $0.11

* REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017